A recent study has demonstrated that circadian rhythms in mice may control the extent of response to vaccination of CD8 T cells to antigen presentation by dendritic cells.
Browsing: immune response
Researchers have identified natural killer cells as a potential therapeutic target for the treatment of neuropathic pain. The immune cells can selectively degenerate axons, allowing repair of damaged nerves.
The link between emotional processing and our immune responses – as seen in the placebo effect – could lead to new avenues for treating psychiatric diseases, according to research.
Research has demonstrated that boosting the immune system could offer a novel treatment modality for Alzheimer’s disease.
Scientists reveal that a molecule normally used by the immune system to prevent excessive damage may actually contribute to chronic white matter injury.
Analysis of three studies looks at the role of octagam® for chronic inflammatory demyelinating polyneuropathy patients
Editor’s summary considering the effectiveness and tolerability of octagam in patients with chronic inflammatory demyelinating polyneuropathy.
Researchers discover latent human herpes virus 6 may interfere with the brains ability to repair damaged myelin in brain diseases such as multiple sclerosis.
Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.
NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment targeting Epstein-Barr virus
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis.
Autoantibodies occur in many different nervous system disorders, and are increasingly being found in disorders not traditionally associated with the immune system. Determining if the autoantibodies play a functional or pathogenic role is critical in selecting the most appropriate treatment options.